Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome.


Journal

Cancer immunology research
ISSN: 2326-6074
Titre abrégé: Cancer Immunol Res
Pays: United States
ID NLM: 101614637

Informations de publication

Date de publication:
01 2019
Historique:
received: 07 03 2018
revised: 16 08 2018
accepted: 01 11 2018
pubmed: 8 11 2018
medline: 5 3 2020
entrez: 8 11 2018
Statut: ppublish

Résumé

Melanoma is an immunogenic neoplasm infiltrated by T cells, although these adaptive T cells usually fail to eradicate the tumor. Plasmacytoid dendritic cells (PDCs) are potent regulators of the adaptive immune response and can eliminate melanoma cells via TLR-mediated effector functions. The PDC compartment is maintained by progressively restricted bone marrow progenitors. Terminally differentiated PDCs exit the bone marrow into the circulation, then home to lymph nodes and inflamed peripheral tissues. Infiltration by PDCs is documented in various cancers. However, their role within the melanoma immune contexture is not completely known. We found that in locoregional primary cutaneous melanoma (PCM), PDC infiltration was heterogeneous, occurred early, and was recurrently localized at the invasive margin, the site where PDCs interact with CD8

Identifiants

pubmed: 30401679
pii: 2326-6066.CIR-18-0141
doi: 10.1158/2326-6066.CIR-18-0141
doi:

Substances chimiques

Chemokines 0
KRAS protein, human 0
BRAF protein, human EC 2.7.11.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-28

Commentaires et corrections

Type : ErratumIn

Informations de copyright

©2018 American Association for Cancer Research.

Auteurs

Raffaella Vescovi (R)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Matilde Monti (M)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Daniele Moratto (D)

Laboratory of Genetic Disorders of Childhood, "Angelo Nocivelli" Institute for Molecular Medicine, Spedali Civili, Brescia, Italy.

Lucia Paolini (L)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Francesca Consoli (F)

Oncology Unit, ASST Spedali Civili di Brescia, Italy.

Luisa Benerini (L)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Laura Melocchi (L)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Stefano Calza (S)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Mariella Chiudinelli (M)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Giulio Rossi (G)

Pathology Unit, Azienda Romagna, Hospital Santa Maria delle Croci, Ravenna, Italy.

Mattia Bugatti (M)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Michele Maio (M)

Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy.

Ester Fonsatti (E)

Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy.

Camillo Farisoglio (C)

Dermathology Unit, ASST Spedali Civili di Brescia, Italy.

Michele Simbolo (M)

ARC-Net Research Centre and Department of Diagnostics and Public Health, Section of Pathology, Università degli Studi di Verona, Verona, Italy.

Camillo Almici (C)

Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, ASST Spedali Civili, Brescia, Italy.

Rosanna Verardi (R)

Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, ASST Spedali Civili, Brescia, Italy.

Aldo Scarpa (A)

ARC-Net Research Centre and Department of Diagnostics and Public Health, Section of Pathology, Università degli Studi di Verona, Verona, Italy.

Paolo Bergese (P)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Ausilia Manganoni (A)

Dermathology Unit, ASST Spedali Civili di Brescia, Italy.

Fabio Facchetti (F)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

William Vermi (W)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. william.vermi@unibs.it.
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH